DUBLIN, Jan. 10, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received approval from Japan's Ministry of Health, Labor and Welfare ...
DUBLIN, May 1, 2023 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra™ AV2 ...
A novel bipolar conduction system pacing implantable cardioverter defibrillator lead demonstrated short-term safety and ...
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), ...
Abbott Laboratories (NYSE:ABT) released new late breaking clinical data on its advanced cardiac devices, focusing on pulsed ...
New temporary pacing system is designed to improve patient safety, reduce costs, and enhance efficiency for transcatheter heart valve (THV) procedures. SAN FRANCISCO, March 31, 2026 /PRNewswire/ -- ...
For patients with heart failure, a reduced ejection fraction, and an indication for cardiac resynchronization therapy (CRT), using His-Purkinje conduction system pacing (HPCSP) is safe and feasible ...
DUBLIN, Jan. 5, 2024 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced it has received CE (Conformité Européenne) Mark for its Micra™ AV2 and Micra™ VR2, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results